Skip to main content


Meet with our product experts in one-on-one virtual sessions

Set Up a Meeting
Quick Connect

News

The winner of the Corporate social responsibility (CSR) Initiative of the year at Global generics & Biosimilars Awards

The winner of the Corporate social responsibility (CSR) Initiative of the year at Global generics & Biosimilars Awards

Dr. Reddy’s won the CSR Initiative of the Year Award for our efforts in the light of the pandemic. We have various CSR initiatives in the areas of Education, Health and Skilling and Livelihood to empower the communities. The COVID-19 pandemic, however, posed a challenge in reaching out to the communities, especially in this hour of need.

The nationwide lockdown in India had severely impacted all the three pillars – education, healthcare, and livelihood, affecting a huge population from the less privileged communities. Thus, staying true its social commitment, in collaboration with its partners, the organization undertook several measures to support these communities to the best possible extent.

To know more about our API Portfolio, write to us at: api@drreddys.com.

CSR Initiative

The winner of the Corporate social responsibility (CSR) Initiative of the year at Global generics & Biosimilars Awards

Contact Us

Please fill in the following form and we'll get back to you shortly.

Disclaimer

No information in this catalog - including any reference to any product or service - constitutes an offer for sale, or be construed as representing an offer for sale. Products protected under valid patents are not offered or supplied for commercial use. However, the research quantities of such products may be offered for the purpose of regulatory submissions, wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities. Products protected under valid patents in India are not available for commercial use but would be available for Section 107A purposes.

X
Checked out our

API Linkedin
page yet?

Follow this page to explore how our offerings can accelerate your formulation success

Click here to visit